Skip to content 
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois. more
| Time Frame | GEHC | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 3.02% | 1.51% | -1.5% |
| 1-Month Return | 3.53% | 1.46% | 0.6% |
| 3-Month Return | 15.55% | 3.94% | 2.43% |
| 6-Month Return | 11.53% | 16.03% | 6.01% |
| 1-Year Return | -11.93% | 9.1% | 11.48% |
| 3-Year Return | 11.53% | 19.46% | 67.52% |
| 5-Year Return | 36.02% | 35.29% | 73.75% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 17.59B | 18.34B | 19.55B | 19.67B | 20.63B | [{"date":"2021-12-31","value":85.26,"profit":true},{"date":"2022-12-31","value":88.93,"profit":true},{"date":"2023-12-31","value":94.8,"profit":true},{"date":"2024-12-31","value":95.38,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 10.41B | 11.16B | 11.63B | 11.47B | 12.38B | [{"date":"2021-12-31","value":84.11,"profit":true},{"date":"2022-12-31","value":90.18,"profit":true},{"date":"2023-12-31","value":93.96,"profit":true},{"date":"2024-12-31","value":92.64,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 7.17B | 7.18B | 7.92B | 8.21B | 8.25B | [{"date":"2021-12-31","value":86.99,"profit":true},{"date":"2022-12-31","value":87.05,"profit":true},{"date":"2023-12-31","value":96.06,"profit":true},{"date":"2024-12-31","value":99.49,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Margin | 40.80% | 39.14% | 40.52% | 41.71% | 39.99% | [{"date":"2021-12-31","value":97.81,"profit":true},{"date":"2022-12-31","value":93.84,"profit":true},{"date":"2023-12-31","value":97.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":95.87,"profit":true}] |
| Operating Expenses | 4.38B | 4.66B | 5.49B | 5.58B | 5.49B | [{"date":"2021-12-31","value":78.48,"profit":true},{"date":"2022-12-31","value":83.46,"profit":true},{"date":"2023-12-31","value":98.33,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":98.3,"profit":true}] |
| Operating Income | 2.79B | 2.52B | 2.44B | 2.63B | 2.76B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.23,"profit":true},{"date":"2023-12-31","value":87.12,"profit":true},{"date":"2024-12-31","value":93.92,"profit":true},{"date":"2025-12-31","value":98.82,"profit":true}] |
| Total Non-Operating Income/Expense | 74.00M | (87.00M) | (590.00M) | (549.00M) | (393.00M) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-117.57,"profit":false},{"date":"2023-12-31","value":-797.3,"profit":false},{"date":"2024-12-31","value":-741.89,"profit":false},{"date":"2025-12-31","value":-531.08,"profit":false}] |
| Pre-Tax Income | 2.88B | 2.51B | 2.36B | 2.58B | 2.77B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":87.37,"profit":true},{"date":"2023-12-31","value":82.12,"profit":true},{"date":"2024-12-31","value":89.77,"profit":true},{"date":"2025-12-31","value":96.28,"profit":true}] |
| Income Taxes | 600.00M | 563.00M | (743.00M) | 531.00M | 614.00M | [{"date":"2021-12-31","value":97.72,"profit":true},{"date":"2022-12-31","value":91.69,"profit":true},{"date":"2023-12-31","value":-121.01,"profit":false},{"date":"2024-12-31","value":86.48,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income After Taxes | 2.27B | 1.95B | 3.10B | 2.05B | 2.15B | [{"date":"2021-12-31","value":73.29,"profit":true},{"date":"2022-12-31","value":62.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":66.04,"profit":true},{"date":"2025-12-31","value":69.39,"profit":true}] |
| Income From Continuous Operations | 2.27B | 1.95B | 1.62B | 2.05B | 2.15B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.67,"profit":true},{"date":"2023-12-31","value":71.12,"profit":true},{"date":"2024-12-31","value":90.11,"profit":true},{"date":"2025-12-31","value":94.68,"profit":true}] |
| Income From Discontinued Operations | 18.00M | 18.00M | - | - | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 2.25B | 1.92B | 3.10B | 1.99B | 2.08B | [{"date":"2021-12-31","value":72.39,"profit":true},{"date":"2022-12-31","value":61.73,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":64.21,"profit":true},{"date":"2025-12-31","value":67.14,"profit":true}] |
| EPS (Diluted) | - | 4.22 | 3.94 | 4.61 | 4.43 | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":91.54,"profit":true},{"date":"2023-12-31","value":85.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":96.1,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| GEHC | |
|---|---|
| Cash Ratio | 0.50 |
| Current Ratio | 1.18 |
| Quick Ratio | 0.93 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| GEHC | |
|---|---|
| ROA (LTM) | 5.47% |
| ROE (LTM) | 22.38% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| GEHC | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.71 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.28 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| GEHC | |
|---|---|
| Trailing PE | 17.66 |
| Forward PE | 16.95 |
| P/S (TTM) | 1.78 |
| P/B | 3.53 |
| Price/FCF | 40 |
| EV/R | 2.06 |
| EV/Ebitda | 11.25 |
| PEG | 2.25 |
GE HealthCare Technologies Inc. (GEHC) share price today is $81.61
Yes, Indians can buy shares of GE HealthCare Technologies Inc. (GEHC) on Vested. To buy
Yes, you can purchase fractional shares of GE HealthCare Technologies Inc. (GEHC) via the Vested app. You can start investing in GE HealthCare Technologies Inc. (GEHC) with a minimum investment of $1.
You can invest in shares of GE HealthCare Technologies Inc. (GEHC) via Vested in three simple steps:
The 52-week high price of GE HealthCare Technologies Inc. (GEHC) is $93.09. The 52-week low price of GE HealthCare Technologies Inc. (GEHC) is $57.54.
The price-to-earnings (P/E) ratio of GE HealthCare Technologies Inc. (GEHC) is 17.6571
The price-to-book (P/B) ratio of GE HealthCare Technologies Inc. (GEHC) is 3.53
The dividend yield of GE HealthCare Technologies Inc. (GEHC) is 0.18%
The market capitalization of GE HealthCare Technologies Inc. (GEHC) is $36.61B
The stock symbol (or ticker) of GE HealthCare Technologies Inc. is GEHC
Consider the share price of GE HealthCare Technologies Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether GE HealthCare Technologies Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in GE HealthCare Technologies Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the GE HealthCare Technologies Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of GE HealthCare Technologies Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that GE HealthCare Technologies Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
